Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005739 | mitochondrion | 5 | 1 |
GO:0031019 | mitochondrial mRNA editing complex | 3 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0045293 | mRNA editing complex | 3 | 1 |
GO:0098798 | mitochondrial protein-containing complex | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
GO:1902494 | catalytic complex | 2 | 1 |
Related structures:
AlphaFold database: A0A3S5H616
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009451 | RNA modification | 5 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0010035 | response to inorganic substance | 3 | 1 |
GO:0010038 | response to metal ion | 4 | 1 |
GO:0016070 | RNA metabolic process | 5 | 1 |
GO:0016071 | mRNA metabolic process | 6 | 1 |
GO:0016556 | mRNA modification | 6 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0042221 | response to chemical | 2 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043412 | macromolecule modification | 4 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0050896 | response to stimulus | 1 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000175 | 3'-5'-RNA exonuclease activity | 7 | 1 |
GO:0003824 | catalytic activity | 1 | 1 |
GO:0004518 | nuclease activity | 4 | 1 |
GO:0004519 | endonuclease activity | 5 | 1 |
GO:0004521 | RNA endonuclease activity | 5 | 1 |
GO:0004527 | exonuclease activity | 5 | 1 |
GO:0004532 | RNA exonuclease activity | 5 | 1 |
GO:0004540 | RNA nuclease activity | 4 | 1 |
GO:0005488 | binding | 1 | 3 |
GO:0008270 | zinc ion binding | 6 | 1 |
GO:0008408 | 3'-5' exonuclease activity | 6 | 1 |
GO:0016787 | hydrolase activity | 2 | 1 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 1 |
GO:0016796 | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 6 | 1 |
GO:0016891 | RNA endonuclease activity, producing 5'-phosphomonoesters | 6 | 1 |
GO:0016893 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 6 | 1 |
GO:0016896 | RNA exonuclease activity, producing 5'-phosphomonoesters | 6 | 1 |
GO:0043167 | ion binding | 2 | 1 |
GO:0043169 | cation binding | 3 | 1 |
GO:0046872 | metal ion binding | 4 | 1 |
GO:0046914 | transition metal ion binding | 5 | 1 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 1 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 1 |
GO:0003676 | nucleic acid binding | 3 | 2 |
GO:0003677 | DNA binding | 4 | 2 |
GO:0003697 | single-stranded DNA binding | 5 | 2 |
GO:0097159 | organic cyclic compound binding | 2 | 2 |
GO:1901363 | heterocyclic compound binding | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 251 | 255 | PF00656 | 0.726 |
CLV_NRD_NRD_1 | 49 | 51 | PF00675 | 0.606 |
CLV_NRD_NRD_1 | 58 | 60 | PF00675 | 0.586 |
CLV_PCSK_FUR_1 | 260 | 264 | PF00082 | 0.525 |
CLV_PCSK_KEX2_1 | 262 | 264 | PF00082 | 0.569 |
CLV_PCSK_KEX2_1 | 49 | 51 | PF00082 | 0.584 |
CLV_PCSK_KEX2_1 | 58 | 60 | PF00082 | 0.568 |
CLV_PCSK_PC1ET2_1 | 262 | 264 | PF00082 | 0.568 |
CLV_PCSK_SKI1_1 | 262 | 266 | PF00082 | 0.484 |
DEG_SPOP_SBC_1 | 163 | 167 | PF00917 | 0.700 |
DEG_SPOP_SBC_1 | 169 | 173 | PF00917 | 0.646 |
DEG_SPOP_SBC_1 | 182 | 186 | PF00917 | 0.739 |
DEG_SPOP_SBC_1 | 214 | 218 | PF00917 | 0.739 |
DOC_CKS1_1 | 316 | 321 | PF01111 | 0.694 |
DOC_CKS1_1 | 424 | 429 | PF01111 | 0.495 |
DOC_MAPK_gen_1 | 142 | 150 | PF00069 | 0.579 |
DOC_MAPK_MEF2A_6 | 391 | 399 | PF00069 | 0.521 |
DOC_MAPK_MEF2A_6 | 478 | 487 | PF00069 | 0.354 |
DOC_PP2B_PxIxI_1 | 482 | 488 | PF00149 | 0.354 |
DOC_PP4_FxxP_1 | 200 | 203 | PF00568 | 0.622 |
DOC_PP4_FxxP_1 | 424 | 427 | PF00568 | 0.431 |
DOC_PP4_FxxP_1 | 446 | 449 | PF00568 | 0.498 |
DOC_SPAK_OSR1_1 | 459 | 463 | PF12202 | 0.385 |
DOC_USP7_MATH_1 | 164 | 168 | PF00917 | 0.633 |
DOC_USP7_MATH_1 | 169 | 173 | PF00917 | 0.600 |
DOC_USP7_MATH_1 | 181 | 185 | PF00917 | 0.591 |
DOC_USP7_MATH_1 | 207 | 211 | PF00917 | 0.696 |
DOC_USP7_MATH_1 | 215 | 219 | PF00917 | 0.700 |
DOC_USP7_MATH_1 | 314 | 318 | PF00917 | 0.724 |
DOC_USP7_MATH_1 | 330 | 334 | PF00917 | 0.602 |
DOC_USP7_MATH_1 | 348 | 352 | PF00917 | 0.572 |
DOC_USP7_UBL2_3 | 138 | 142 | PF12436 | 0.529 |
DOC_WW_Pin1_4 | 172 | 177 | PF00397 | 0.645 |
DOC_WW_Pin1_4 | 183 | 188 | PF00397 | 0.634 |
DOC_WW_Pin1_4 | 191 | 196 | PF00397 | 0.503 |
DOC_WW_Pin1_4 | 216 | 221 | PF00397 | 0.687 |
DOC_WW_Pin1_4 | 230 | 235 | PF00397 | 0.603 |
DOC_WW_Pin1_4 | 305 | 310 | PF00397 | 0.682 |
DOC_WW_Pin1_4 | 315 | 320 | PF00397 | 0.748 |
DOC_WW_Pin1_4 | 33 | 38 | PF00397 | 0.472 |
DOC_WW_Pin1_4 | 423 | 428 | PF00397 | 0.417 |
DOC_WW_Pin1_4 | 71 | 76 | PF00397 | 0.635 |
LIG_14-3-3_CanoR_1 | 59 | 67 | PF00244 | 0.676 |
LIG_14-3-3_CanoR_1 | 97 | 105 | PF00244 | 0.588 |
LIG_CaM_IQ_9 | 267 | 283 | PF13499 | 0.410 |
LIG_Clathr_ClatBox_1 | 147 | 151 | PF01394 | 0.564 |
LIG_EVH1_2 | 38 | 42 | PF00568 | 0.474 |
LIG_FHA_1 | 116 | 122 | PF00498 | 0.486 |
LIG_FHA_1 | 150 | 156 | PF00498 | 0.637 |
LIG_FHA_1 | 271 | 277 | PF00498 | 0.421 |
LIG_FHA_1 | 436 | 442 | PF00498 | 0.360 |
LIG_FHA_1 | 461 | 467 | PF00498 | 0.371 |
LIG_FHA_1 | 88 | 94 | PF00498 | 0.586 |
LIG_FHA_2 | 29 | 35 | PF00498 | 0.467 |
LIG_FHA_2 | 316 | 322 | PF00498 | 0.672 |
LIG_LIR_Apic_2 | 422 | 427 | PF02991 | 0.435 |
LIG_LIR_Apic_2 | 445 | 449 | PF02991 | 0.497 |
LIG_LIR_Gen_1 | 433 | 442 | PF02991 | 0.372 |
LIG_LIR_Nem_3 | 118 | 122 | PF02991 | 0.451 |
LIG_LIR_Nem_3 | 433 | 439 | PF02991 | 0.400 |
LIG_LIR_Nem_3 | 445 | 450 | PF02991 | 0.397 |
LIG_LYPXL_yS_3 | 482 | 485 | PF13949 | 0.357 |
LIG_MYND_1 | 39 | 43 | PF01753 | 0.474 |
LIG_PDZ_Class_2 | 492 | 497 | PF00595 | 0.380 |
LIG_Pex14_2 | 196 | 200 | PF04695 | 0.660 |
LIG_SH2_CRK | 480 | 484 | PF00017 | 0.377 |
LIG_SH2_STAT3 | 358 | 361 | PF00017 | 0.682 |
LIG_SH2_STAT5 | 358 | 361 | PF00017 | 0.548 |
LIG_SH2_STAT5 | 409 | 412 | PF00017 | 0.470 |
LIG_SH3_3 | 313 | 319 | PF00018 | 0.776 |
LIG_SH3_3 | 364 | 370 | PF00018 | 0.479 |
LIG_SH3_3 | 375 | 381 | PF00018 | 0.465 |
LIG_SH3_3 | 426 | 432 | PF00018 | 0.437 |
LIG_TRAF2_1 | 256 | 259 | PF00917 | 0.686 |
LIG_TRAF2_1 | 380 | 383 | PF00917 | 0.448 |
MOD_CK1_1 | 165 | 171 | PF00069 | 0.638 |
MOD_CK1_1 | 172 | 178 | PF00069 | 0.643 |
MOD_CK1_1 | 186 | 192 | PF00069 | 0.759 |
MOD_CK1_1 | 216 | 222 | PF00069 | 0.717 |
MOD_CK1_1 | 295 | 301 | PF00069 | 0.572 |
MOD_CK1_1 | 315 | 321 | PF00069 | 0.764 |
MOD_CK1_1 | 77 | 83 | PF00069 | 0.690 |
MOD_CK1_1 | 88 | 94 | PF00069 | 0.727 |
MOD_CK2_1 | 242 | 248 | PF00069 | 0.691 |
MOD_CK2_1 | 28 | 34 | PF00069 | 0.471 |
MOD_CK2_1 | 315 | 321 | PF00069 | 0.787 |
MOD_GlcNHglycan | 172 | 175 | PF01048 | 0.646 |
MOD_GlcNHglycan | 188 | 191 | PF01048 | 0.730 |
MOD_GlcNHglycan | 230 | 233 | PF01048 | 0.628 |
MOD_GlcNHglycan | 250 | 253 | PF01048 | 0.639 |
MOD_GlcNHglycan | 294 | 297 | PF01048 | 0.562 |
MOD_GlcNHglycan | 299 | 302 | PF01048 | 0.583 |
MOD_GlcNHglycan | 328 | 331 | PF01048 | 0.739 |
MOD_GlcNHglycan | 332 | 335 | PF01048 | 0.667 |
MOD_GlcNHglycan | 44 | 47 | PF01048 | 0.515 |
MOD_GlcNHglycan | 455 | 458 | PF01048 | 0.503 |
MOD_GlcNHglycan | 490 | 493 | PF01048 | 0.474 |
MOD_GlcNHglycan | 62 | 65 | PF01048 | 0.526 |
MOD_GlcNHglycan | 76 | 79 | PF01048 | 0.696 |
MOD_GSK3_1 | 163 | 170 | PF00069 | 0.624 |
MOD_GSK3_1 | 18 | 25 | PF00069 | 0.517 |
MOD_GSK3_1 | 182 | 189 | PF00069 | 0.672 |
MOD_GSK3_1 | 216 | 223 | PF00069 | 0.623 |
MOD_GSK3_1 | 28 | 35 | PF00069 | 0.501 |
MOD_GSK3_1 | 291 | 298 | PF00069 | 0.499 |
MOD_GSK3_1 | 326 | 333 | PF00069 | 0.606 |
MOD_GSK3_1 | 37 | 44 | PF00069 | 0.663 |
MOD_GSK3_1 | 419 | 426 | PF00069 | 0.474 |
MOD_N-GLC_1 | 248 | 253 | PF02516 | 0.636 |
MOD_N-GLC_1 | 348 | 353 | PF02516 | 0.598 |
MOD_N-GLC_2 | 394 | 396 | PF02516 | 0.371 |
MOD_NEK2_1 | 228 | 233 | PF00069 | 0.635 |
MOD_NEK2_1 | 265 | 270 | PF00069 | 0.419 |
MOD_NEK2_1 | 416 | 421 | PF00069 | 0.431 |
MOD_NEK2_1 | 460 | 465 | PF00069 | 0.432 |
MOD_NEK2_2 | 115 | 120 | PF00069 | 0.483 |
MOD_NEK2_2 | 270 | 275 | PF00069 | 0.406 |
MOD_PIKK_1 | 471 | 477 | PF00454 | 0.507 |
MOD_PKA_2 | 96 | 102 | PF00069 | 0.676 |
MOD_Plk_1 | 348 | 354 | PF00069 | 0.594 |
MOD_Plk_4 | 37 | 43 | PF00069 | 0.551 |
MOD_Plk_4 | 77 | 83 | PF00069 | 0.624 |
MOD_ProDKin_1 | 172 | 178 | PF00069 | 0.647 |
MOD_ProDKin_1 | 183 | 189 | PF00069 | 0.634 |
MOD_ProDKin_1 | 191 | 197 | PF00069 | 0.499 |
MOD_ProDKin_1 | 216 | 222 | PF00069 | 0.688 |
MOD_ProDKin_1 | 230 | 236 | PF00069 | 0.604 |
MOD_ProDKin_1 | 305 | 311 | PF00069 | 0.685 |
MOD_ProDKin_1 | 315 | 321 | PF00069 | 0.749 |
MOD_ProDKin_1 | 33 | 39 | PF00069 | 0.470 |
MOD_ProDKin_1 | 423 | 429 | PF00069 | 0.421 |
MOD_ProDKin_1 | 71 | 77 | PF00069 | 0.635 |
TRG_DiLeu_BaEn_2 | 260 | 266 | PF01217 | 0.636 |
TRG_ENDOCYTIC_2 | 482 | 485 | PF00928 | 0.357 |
TRG_ER_diArg_1 | 48 | 50 | PF00400 | 0.611 |
TRG_ER_diArg_1 | 58 | 60 | PF00400 | 0.581 |
TRG_ER_diArg_1 | 9 | 12 | PF00400 | 0.527 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I1P1 | Leptomonas seymouri | 57% | 100% |
A0A0S4IKI2 | Bodo saltans | 44% | 100% |
A0A1X0NPK8 | Trypanosomatidae | 47% | 100% |
A0A422N9Y4 | Trypanosoma rangeli | 45% | 100% |
A4H556 | Leishmania braziliensis | 72% | 96% |
A4HTD3 | Leishmania infantum | 100% | 100% |
C9ZUI1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 47% | 100% |
E9ALC6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |
Q4QIH9 | Leishmania major | 90% | 99% |
V5DQ35 | Trypanosoma cruzi | 48% | 100% |